The Container Store has filed for bankruptcy protection as the storage and organizational goods retailer with roots dating back to the 1970s grapples with mounting losses and cash flow shortages. Under Chapter 11 protection, The Container Store will continue to operate while it restructures. The company said Sunday that it had filed for bankruptcy protection in Texas.
Moncler Group Tops Dow Jones Sustainability Indices for Sixth Year in a Row
The group was acknowledged as industry leader of the “textile, apparel and luxury goods” sector with the highest score in the S&P Global Corporate Sustainability Assessment.
MicroStrategy’s Long-Shot S&P 500 Bid Stokes Wall Street Agita
(Bloomberg) -- To Michael Saylor’s online fanbase, it’s the next step in the great normalization of crypto: Bitcoin proxy MicroStrategy Inc. enters the S&P 500 next year, forcing the likes of index-tracking funds to buy his controversial company en masse. Whether they like it or not.Most Read from BloombergHo Chi Minh City Opens First Metro Line After Years of DelayReviving a Little-Known Modernist Landmark in BuffaloThe Architects Who Built MiamiNew York’s Congestion Pricing Plan Still Faces Le
Metaplanet Picks Up Record 620 Bitcoin as XRP Leads Market Slide
The purchase did little to buoy sentiment for bitcoin, which recorded its first seven-day loss since early November.
5 Things to Know Before the Stock Market Opens
News of the Day for Dec. 23, 2024
Brazil Analysts See Key Rate at 15% in June, More Inflation
(Bloomberg) -- Brazil economists raised their forecasts for inflation and borrowing costs in 2025 after central bankers reinforced their commitment to extend large interest rate hikes into early next year. Most Read from BloombergHo Chi Minh City Opens First Metro Line After Years of DelayThe Architects Who Built MiamiReviving a Little-Known Modernist Landmark in BuffaloNew York’s Congestion Pricing Plan Still Faces Legal HurdlesNew York City’s Historic Preservation Movement Is Having a Midlife
Hot Obesity Drug Market Will Keep Investors Gripped Next Year
(Bloomberg) -- Disappointing trial results for Novo Nordisk A/S’s experimental obesity shot capped a volatile year for investors in drug developers vying for a piece of pharma’s hottest market.Most Read from BloombergHo Chi Minh City Opens First Metro Line After Years of DelayReviving a Little-Known Modernist Landmark in BuffaloThe Architects Who Built MiamiNew York’s Congestion Pricing Plan Still Faces Legal HurdlesNew York City’s Historic Preservation Movement Is Having a Midlife CrisisNovo sh